Martin Cuesta

[NEJM @NEJM]

For a man with obesity, would you recommend the initiation of semaglutide therapy or bariatric and metabolic surgery? Read the case vignette and essays on both treatment options and cast your vote: https://t.co/w9K7IqwAQi

[Sergio Zúñiga @medicosergio]

Hagamos y recomendemos el #ejercicio 🏋🏻‍♀️⛹🏻‍♀️🏊🏻‍♂️🚴🏻‍♂️

Lee, A. K., & Muhamad, R. B. (2023). Physically active primary care physicians consult more on physical activity and exercise for patients: A public teaching-hospital study. Safety and Health in Medical Settings. https://t.co/K2SuR3kepO

[Beyond Type 1 @BeyondType1]

NEWS: Today the FDA approved Tandem’s newest insulin pump, Mobi. This insulin pump is fully controllable from a mobile app and is now the world’s smallest durable automated insulin delivery system.
https://t.co/9pN1CCzWeU

[American Diabetes Association - DiabetesPro @ADA_DiabetesPro]

Noninvasive blood glucose monitor compares favorably to fingersticks in diabetes https://t.co/sANIAOJPn2

[Nature Reviews Drug Discovery @NatRevDrugDisc]

FDA approves first cell therapy for type 1 diabetes https://t.co/tvkOnOEUBK

[Diabetes Care, an ADA research journal 🌟 @DiabetesCareADA]

A Danish nationwide register study found an increase in T1D incidence during Apr-Jun 2021 compared to Apr-Jun 2015-2019, but this could not be attributed to the COVID-19 pandemic. @ADA_Pubs

Read Here➡️https://t.co/mgPf9z9eoS

[Diabetes Care, an ADA research journal 🌟 @DiabetesCareADA]

A feasibility study of a pregnancy-specific (63-140 mg/dL) zone-MPC hybrid closed-loop system in pregnancies with type 1 diabetes showed significant improvement in time in range during home use. @ADA_Pubs

Read Here➡️https://t.co/34lhIKZuIq

[Thyroid Federation @ThyroidFed]

The European Society of Endocrinology #ESE published a new annex to the last year’s Milano Declaration which includes simple steps to take towards better #hormonehealth: reduce exposure to #endocrinedisrupting #chemicals, #plastics, #cosmetics, ensure adequate #vitaminD intake.

[Diabetes Care, an ADA research journal 🌟 @DiabetesCareADA]

Concerning very low rates of #glucagon prescription among ppl w @ESKD dialysis and #T1D (3.5 - 3.7%) & #T2D (1.3- 1.4%) in the US @NIDDKgov #USRDS

@RodolfoJGalindo @RozalinaMD @mkali_twindad @egdrc @umiamimedicine @ADA_Pubs

Read Here➡️https://t.co/4EwmG5w1Tm

[U.S. FDA @FDA]

Today, we approved the first allogeneic (donor) pancreatic islet cellular therapy made from deceased donor pancreatic cells for the treatment of type 1 diabetes. https://t.co/cICX8YO3xb

[Shivani Misra @ShivaniM_KC]

A few key members missing but say hello to some of the joint ADA/EASD committee updating the DKA/HHS guidelines 👋

For the first time with unified international definitions & Rx recommendations

Boy oh boy have we had some fights 🥊😂 😉

*Will be published soon*

[Rosa Casañ Fernandez @RosaCasan]

Una gran noticia la participación en la ADA del Dr Gómez Peralta, coordinador del área de conocimiento @diabeteSEEN de la @sociedadSEEN

[Diabetes Care, an ADA research journal 🌟 @DiabetesCareADA]

The advanced hybrid closed loop Minimed 780G is safe also in children below the age of 7 years with a total daily insulin dose below 8 U and is feasible soon after diagnosis @ADA_Pubs

Read Here➡️https://t.co/eJMmQKWgso

[Daniel J Drucker @DanielJDrucker]

A new review-heterogeneity and subtypes of type 1 #diabetes #T1D @NatureRevEndo @ngmorgan1 @T1DExchange @JDRF #genetics https://t.co/WPStAMOjB4

[Scott Isaacs @scottisaacsmd]

Low skeletal muscle mass + abdominal obesity additively increases the risk of type 2 diabetes independent of the glycometabolic parameters.
https://t.co/6QL506OUsg

[Carmen Martínez González @carmendiri]

Demasiada listas de médicos de familia y pediatras inexistentes, y listas de desbordamiento (50—60 pacientes que no caben en las agendas pero se ven, aunque le cueste la salud al propio médico ) ...
Todo muy surrealista
#SanidadPúblicaSeDefiende
👇

[Serafin Murillo @serafinmurillo]

Imprescindible si vives con diabetes!!

[Cristina Tejera @cristinatejerap]

Gracias @SAEDYN_ por invitarme a participar en las II Jornadas de Tecnologías aplicadas a la diabetes hablando sobre #diabetesydeporte junto con un grande @serafinmurillo Calorcito cordobés y compis que te hacen sentir como en casa! 😎😉

[DIEGO FERNANDEZ GARCIA @diegofe21784801]

Un placer compartir taller con @MartinCuesta5 sobre tecnología aplicada en la diabetes en el ámbito hospitalario. Mucho por mejorar @SAEDYN_ @marietabrocca @manoloromz @cristinatejerap @CristobMorales @elendocrino

[Martin Cuesta @MartinCuesta5]

@diegofe21784801 @SAEDYN_ @marietabrocca @manoloromz @cristinatejerap @CristobMorales @elendocrino Muchas gracias por la invitación @diegofe21784801! Ha sido un placer!